Hamburg, Germany – September 04, 2026 -- Furuno Electric Co., Ltd. will offer a new SOLION-100 terminal built on Iridium Certus 100 technology, combining GMDSS, Ship Security Alert System and Long-Range Identification and Tracking capabilities into a single platform for newbuild and retrofit vessels.

HONG KONG – September 04, 2026 -- Global professional buyer pre-registration for the October 2026 Global Sources Hong Kong Shows is running 25% ahead of the same period last year, with North America and Europe driving the sharpest gains, organizers said.

Singapore – September 04, 2026 -- Nasdaq-listed Amber International Holding Limited (Nasdaq: AMBR) has rebranded from Amber Premium to AMBR, repositioning itself as an agentic AI company building specialized agents for finance, enterprise, and growth.

NEW YORK – September 04, 2026 -- Haut.AI has commercially launched Hair Analysis, an AI-powered hair assessment tool that converts a smartphone selfie and short questionnaire into personalized haircare product recommendations for beauty brands and retailers worldwide.

Los Angeles – September 04, 2026 -- F&F Ventures has launched a $10 million fund with commerce platform SHOPLINE to back consumer brands from pre-seed through Series A, pairing capital with the operating infrastructure that serves more than 700,000 merchants globally.

Fort Lauderdale, Florida – September 04, 2026 -- IGEL has added Teguar to its IGEL Ready ecosystem, certifying the manufacturer's rugged and specialized hardware for use with IGEL OS in healthcare, manufacturing and warehouse settings.

DELRAY BEACH, FLA. – September 04, 2026 -- The global PTFE membranes market is projected to reach $2.84 billion by 2031, up from $2.14 billion in 2026, expanding at a compound annual growth rate of 5.8%, according to MarketsandMarkets.

Dublin – September 03, 2026 -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) reported that Ziihera (zanidatamab-hrii) plus chemotherapy achieved a statistically significant and clinically meaningful overall survival benefit over trastuzumab plus chemotherapy in first-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma (GEA), based on a second interim analysis of the Phase 3 HERIZON-GEA-01 trial.

Dublin – September 03, 2026 -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) reported that Ziihera (zanidatamab-hrii) combined with chemotherapy produced a statistically significant and clinically meaningful overall survival (OS) benefit versus trastuzumab plus chemotherapy in a second interim analysis of the Phase 3 HERIZON-GEA-01 trial in first-line HER2-positive gastroesophageal adenocarcinoma (GEA).

Paris – September 03, 2026 -- CHINT, a global provider of integrated power and energy solutions, presented a full portfolio of grid modernization technologies at CIGRE 2026 in Paris, targeting utilities grappling with surging electricity demand from AI infrastructure and data centers.